TCT-434 Femoral Versus Radial Approach For Coronary Invasive Procedures In Patients With Congestive Heart Failure. Insights from the Propensity Score-Matched Registry  by Buszman, Piotr P. et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B177CATEGORIES OTHER: Vascular Access: Femoral and Closure Devices
KEYWORDS Computed tomography, TAVR, Vascular access
TCT-434
Femoral Versus Radial Approach For Coronary Invasive Procedures In
Patients With Congestive Heart Failure. Insights from the Propensity
Score-Matched Registry
Piotr P. Buszman,1 Marek Gierlotka,2 Michal Hawranek,2 Lukasz Pyka,2
Daniel Ciesla,3 Damian Pres,2 Mateusz Tajstra,4 Andrzej Lekston,5
Mariusz Gasior2
1Silesian Center for Heart Diseases and American Heart of Poland,
Zabrze, Poland; 2Medical University of Silesia, Silesian Center for Heart
Diseases, Zabrze, Poland; 3Silesian Center for Heart Diseases, Zabrze,
AK; 4Medical University of Silesia, Silesian Center for Heart Diseases,
Zabrze, CA; 5Third Department of Cardiology, Medical University of
Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
BACKGROUND Patients with congestive heart failure (CHF) requiring
invasive coronary diagnostics or intervention are at high ischemic as
well as hemorrhagic risk. Therefore, Therefore, the radial approach in
this subset of patients seems to be an appealing strategy.
METHODS This is a prospective, web-based all-comers registry of
patients with CHF who underwent CAG or PCI between 2013 and 2014
via radial (RA) or femoral approach (FA), according to cardiac revas-
cularization guidelines. We evaluated the incidence of a composite
endpoint of bleeding and major vascular adverse events (NET) as well
mortality at 30-day follow-up. Propensity score was used for baseline
characteristics matching and results adjustment.
RESULTS In total 1357 patients were enrolled. The radial approach
was utilized in 277, whereas femoral in 1081 patients. At baseline,
patients in the radial approach arm were slightly younger (64,0  10
vs. 65,9  10 y.o. ; p<0,01), had higher ejection fraction (36,5  14 vs.
33.1 17%; p¼0,04) and less often presented STEMI (6,1% vs.
2,9%;p¼0,05) or NSTEMI (2,9% vs. 8%;p<0,01). On the other hand RA
patients more often presented with atrial ﬁbrillation requiring oral
anticoagulant therapy (42,2% vs. 23%; p<0,01). There was nodifference in the ﬂuroscopy time (11,8 vs. 9,7 min, p¼0,22) as well
contrast volume (125 vs. 150 ml; p¼0,43) between RA and FA, how-
ever the total radiation dose was lower in the FA (0,71 vs. 0,83 Gy;
p¼0,01). At 30 days, the occurrence of NET adverse events (0,36% vs.
2,8%; p¼0,04) transfusion (0% vs. 1,6%; p¼0,04) and death (1,1% vs.
3,2%;p¼0,05) was in favor of RA. After adjustment for baseline
characteristics 277 well-matched pairs were chosen. The occurrence
of major bleeding and vascular events remained in favor of RA (0 vs.
3,2%; p¼0,05. OR: 0.05; 95%CI: 0,1-0,8), whereas the mortality dif-
ference also tended to favor RA (1,0 vs. 2,9%; p¼0,12 OR: 2.7; 95%CI:
0,7-10).
CONCLUSIONS Conclusion. In this registry, radial approach in pa-
tients with CHF undergoing coronary invasive procedures reduced the
incidence of major bleeding events and major vascular complications.
Therefore, we generate the hypothesis that the radial approach should
be considered as primary approach in this subgroup of patients.
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BACKGROUND The feasibility and safety of robotic PCI via trans-
femoral (TFA) access has been demonstrated. However, there is
limited data for robotic PCI via transradial access (TRA). The goal of
this study is to compare clinical and technical outcomes for radial
versus femoral access robotic PCI.
METHODS The multicenter PRECISION post-market registry of robotic
PCI collected clinical and procedural data of robotic PCI procedures
utilizing the CorPath System (Corindus Vascular Robotics, Inc., Wal-
tham, MA) in 9 sites. Technical success was deﬁned as lesions suc-
cessfully treated with robotic PCI and residual stenosis <30%. Clinical
success was deﬁned as <30% residual stenosis and absence of major
adverse cardiovascular events (MACE, which was deﬁned as cardiac
death, myocardial infarction, or clinically driven target vessel revas-
cularization) at hospital discharge or 72 hours post-procedure,
whichever came ﬁrst.
RESULTS Of 273 patients and 334 lesions (at 9 sites) TRA robotic PCI was
done in 156 (57%) and TFA robotic PCI in 117 (43%). The two groups were
comparable except for the TFA access group having a greater proportion
of diabetics and type C lesions (Table 1). TRA and TFA robotic PCI
technical success rates were 93.7% and 85.7%, respectively (P¼0.02)
and clinical success rates were 99.4% and 97.4% respectively (P¼0.32).
Three serious adverse events (SAE) unrelated to the CorPath System
occurred during the study period. Of these 3 SAEs, none were
determined MACE as deﬁned by the protocol.
